# Verdad Advisers, LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1812822. Source: https://holderbook.com/funds/1812822-verdad-advisers-lp/

- Reported value: $104.4M
- Positions: 210
- Weight of the ten largest: 18.1%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| APPLE INC | [AAPL](https://holderbook.com/stocks/AAPL/) | $2.2M | 7,445 | 2.1% | 1 |
| BELITE BIO INC | [BLTE](https://holderbook.com/stocks/BLTE/) | $2.1M | 13,758 | 2.0% | 2 |
| ACADIA PHARMACEUTICALS INC | [ACAD](https://holderbook.com/stocks/ACAD/) | $2.1M | 82,629 | 2.0% | 2 |
| COMCAST CORP NEW | [CMCSA](https://holderbook.com/stocks/CMCSA/) | $2.1M | 84,569 | 2.0% | 3 |
| CHATHAM LODGING TR | [CLDT](https://holderbook.com/stocks/CLDT/) | $1.9M | 140,000 | 1.8% | 3 |
| TENAX THERAPEUTICS INC | [TENX](https://holderbook.com/stocks/TENX/) | $1.8M | 123,174 | 1.7% | 2 |
| SLIDE INS HLDGS INC | [SLDE](https://holderbook.com/stocks/SLDE/) | $1.8M | 91,070 | 1.7% | 2 |
| ZYMEWORKS INC | [ZYME](https://holderbook.com/stocks/ZYME/) | $1.7M | 66,688 | 1.7% | 2 |
| AMN HEALTHCARE SVCS INC | [AMN](https://holderbook.com/stocks/AMN/) | $1.7M | 51,906 | 1.6% | 3 |
| X4 PHARMACEUTICALS INC | [XFOR](https://holderbook.com/stocks/XFOR/) | $1.6M | 352,093 | 1.6% | 1 |
| VERSANT MEDIA GROUP INC | [VSNT](https://holderbook.com/stocks/VSNT/) | $1.6M | 43,503 | 1.5% | 2 |
| NETSCOUT SYS INC | [NTCT](https://holderbook.com/stocks/NTCT/) | $1.4M | 33,128 | 1.4% | 2 |
| WHITEHAWK THERAPEUTICS INC | [WHWK](https://holderbook.com/stocks/WHWK/) | $1.4M | 301,483 | 1.3% | 2 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $1.4M | 5,384 | 1.3% | 6 |
| CONTINEUM THERAPEUTICS INC | [CTNM](https://holderbook.com/stocks/CTNM/) | $1.3M | 81,014 | 1.3% | 2 |
| JADE BIOSCIENCES INC | [JBIO](https://holderbook.com/stocks/JBIO/) | $1.3M | 56,384 | 1.2% | 1 |
| CISCO SYS INC | [CSCO](https://holderbook.com/stocks/CSCO/) | $1.2M | 10,307 | 1.2% | 1 |
| NURIX THERAPEUTICS INC | [NRIX](https://holderbook.com/stocks/NRIX/) | $1.2M | 49,511 | 1.2% | 2 |
| PROTARA THERAPEUTICS INC | [TARA](https://holderbook.com/stocks/TARA/) | $1.2M | 312,249 | 1.1% | 1 |
| BLOOMIN BRANDS INC | [BLMN](https://holderbook.com/stocks/BLMN/) | $1.2M | 130,000 | 1.1% | 3 |
| TYRA BIOSCIENCES INC | [TYRA](https://holderbook.com/stocks/TYRA/) | $1.1M | 36,003 | 1.1% | 1 |
| PAR PAC HOLDINGS INC | [PARR](https://holderbook.com/stocks/PARR/) | $1.1M | 20,000 | 1.1% | 2 |
| EDGEWISE THERAPEUTICS INC | [EWTX](https://holderbook.com/stocks/EWTX/) | $1.1M | 27,234 | 1.1% | 2 |
| ALPHABET INC | [GOOGL](https://holderbook.com/stocks/GOOGL/) | $1.0M | 2,900 | 1.0% | 1 |
| CARTERS INC | [CRI](https://holderbook.com/stocks/CRI/) | $1.0M | 25,000 | 1.0% | 3 |
| VERA THERAPEUTICS INC | [VERA](https://holderbook.com/stocks/VERA/) | $1.0M | 23,487 | 1.0% | 2 |
| NUVALENT INC | [NUVL](https://holderbook.com/stocks/NUVL/) | $1.0M | 8,104 | 1.0% | 1 |
| DIANTHUS THERAPEUTICS INC | [DNTH](https://holderbook.com/stocks/DNTH/) | $980.8K | 10,062 | 0.9% | 2 |
| ACLARIS THERAPEUTICS INC | [ACRS](https://holderbook.com/stocks/ACRS/) | $927.2K | 175,272 | 0.9% | 2 |
| OPPENHEIMER HLDGS INC | [OPY](https://holderbook.com/stocks/OPY/) | $915.3K | 8,673 | 0.9% | 2 |
| VERIZON COMMUNICATIONS INC | [VZ](https://holderbook.com/stocks/VZ/) | $886.5K | 20,938 | 0.8% | 1 |
| MYERS INDS INC | [MYE](https://holderbook.com/stocks/MYE/) | $865.1K | 24,500 | 0.8% | 1 |
| ENLIVEN THERAPEUTICS INC | [ELVN](https://holderbook.com/stocks/ELVN/) | $860.6K | 16,957 | 0.8% | 1 |
| UNIVERSAL INS HLDGS INC | [UVE](https://holderbook.com/stocks/UVE/) | $850.3K | 20,558 | 0.8% | 1 |
| BANK OF NY MELLON CORP | [BNY](https://holderbook.com/stocks/BNY/) | $831.2K | 5,748 | 0.8% | 3 |
| PC CONNECTION INC | [CNXN](https://holderbook.com/stocks/CNXN/) | $809.0K | 11,084 | 0.8% | 1 |
| AMERICAN INTEGRITY INS GROUP | [AII](https://holderbook.com/stocks/AII/) | $794.2K | 42,178 | 0.8% | 3 |
| APPLIED MATLS INC | [AMAT](https://holderbook.com/stocks/AMAT/) | $787.3K | 1,089 | 0.8% | 2 |
| ADAPTHEALTH CORP | [AHCO](https://holderbook.com/stocks/AHCO/) | $781.5K | 75,000 | 0.7% | 2 |
| ALLSTATE CORP | [ALL](https://holderbook.com/stocks/ALL/) | $780.2K | 3,279 | 0.7% | 1 |
| CELLDEX THERAPEUTICS INC NEW | [CLDX](https://holderbook.com/stocks/CLDX/) | $770.4K | 20,704 | 0.7% | 1 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $759.0K | 4,053 | 0.7% | 2 |
| HERITAGE INSURANCE HLDGS INC | [HRTG](https://holderbook.com/stocks/HRTG/) | $745.2K | 28,575 | 0.7% | 5 |
| TD SYNNEX CORPORATION | [SNX](https://holderbook.com/stocks/SNX/) | $743.2K | 2,780 | 0.7% | 2 |
| MOVADO GROUP INC | [MOV](https://holderbook.com/stocks/MOV/) | $737.5K | 18,762 | 0.7% | 2 |
| SMART SAND INC | [SND](https://holderbook.com/stocks/SND/) | $714.8K | 142,684 | 0.7% | 6 |
| VIRIDIAN THERAPEUTICS INC | [VRDN](https://holderbook.com/stocks/VRDN/) | $711.3K | 38,722 | 0.7% | 2 |
| DESIGN THERAPEUTICS INC | [DSGN](https://holderbook.com/stocks/DSGN/) | $688.1K | 47,557 | 0.7% | 2 |
| MARCUS & MILLICHAP INC | [MMI](https://holderbook.com/stocks/MMI/) | $684.9K | 21,972 | 0.7% | 2 |
| MATIV HOLDINGS INC | [MATV](https://holderbook.com/stocks/MATV/) | $681.3K | 90,000 | 0.7% | 1 |
| STONEX GROUP INC | [SNEX](https://holderbook.com/stocks/SNEX/) | $673.3K | 5,682 | 0.6% | 2 |
| CYTOMX THERAPEUTICS INC | [CTMX](https://holderbook.com/stocks/CTMX/) | $661.5K | 176,407 | 0.6% | 2 |
| NET LEASE OFFICE PROPERTIES | [NLOP](https://holderbook.com/stocks/NLOP/) | $654.3K | 58,791 | 0.6% | 2 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $632.6K | 494,201 | 0.6% | 1 |
| OOMA INC | [OOMA](https://holderbook.com/stocks/OOMA/) | $630.6K | 32,810 | 0.6% | 2 |
| ROCKY BRANDS INC | [RCKY](https://holderbook.com/stocks/RCKY/) | $629.1K | 15,254 | 0.6% | 3 |
| JANUX THERAPEUTICS INC | [JANX](https://holderbook.com/stocks/JANX/) | $620.3K | 40,386 | 0.6% | 1 |
| ZOOM COMMUNICATIONS INC | [ZM](https://holderbook.com/stocks/ZM/) | $615.0K | 7,125 | 0.6% | 4 |
| STRUCTURE THERAPEUTICS INC | [GPCR](https://holderbook.com/stocks/GPCR/) | $608.3K | 11,335 | 0.6% | 2 |
| AVALO THERAPEUTICS INC | [AVTX](https://holderbook.com/stocks/AVTX/) | $606.6K | 32,827 | 0.6% | 1 |
| MISTRAS GROUP INC | [MG](https://holderbook.com/stocks/MG/) | $603.2K | 34,526 | 0.6% | 9 |
| VIEMED HEALTHCARE INC | [VMD](https://holderbook.com/stocks/VMD/) | $602.8K | 52,879 | 0.6% | 1 |
| RELMADA THERAPEUTICS INC | [RLMD](https://holderbook.com/stocks/RLMD/) | $602.0K | 86,994 | 0.6% | 2 |
| CLIMB BIO INC | [CLYM](https://holderbook.com/stocks/CLYM/) | $601.3K | 46,115 | 0.6% | 2 |
| CORBUS PHARMACEUTICALS HLDGS | [CRBP](https://holderbook.com/stocks/CRBP/) | $596.6K | 63,603 | 0.6% | 2 |
| BRISTOL-MYERS SQUIBB CO | [BMY](https://holderbook.com/stocks/BMY/) | $591.4K | 10,263 | 0.6% | 1 |
| SECURITY NATL FINL CORP | [SNFCA](https://holderbook.com/stocks/SNFCA/) | $581.4K | 60,000 | 0.6% | 7 |
| USANA HEALTH SCIENCES INC | [USNA](https://holderbook.com/stocks/USNA/) | $556.6K | 26,068 | 0.5% | 2 |
| TALKSPACE INC | [TALK](https://holderbook.com/stocks/TALK/) | $547.3K | 105,252 | 0.5% | 2 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $547.2K | 2,735 | 0.5% | 1 |
| UROGEN PHARMA LTD | [URGN](https://holderbook.com/stocks/URGN/) | $531.4K | 14,440 | 0.5% | 1 |
| ATAIBECKLEY INC | [ATAI](https://holderbook.com/stocks/ATAI/) | $530.6K | 100,681 | 0.5% | 2 |
| CALIFORNIA RES CORP | [CRC](https://holderbook.com/stocks/CRC/) | $528.7K | 10,000 | 0.5% | 3 |
| CULLINAN THERAPEUTICS INC | [CGEM](https://holderbook.com/stocks/CGEM/) | $527.9K | 28,987 | 0.5% | 2 |
| IBIO INC | [IBIO](https://holderbook.com/stocks/IBIO/) | $523.1K | 298,927 | 0.5% | 2 |
| VIATRIS INC | [VTRS](https://holderbook.com/stocks/VTRS/) | $516.1K | 32,500 | 0.5% | 8 |
| INNOVAGE HLDG CORP | [INNV](https://holderbook.com/stocks/INNV/) | $499.3K | 42,139 | 0.5% | 2 |
| HELLO GROUP INC | [MOMO](https://holderbook.com/stocks/MOMO/) | $491.2K | 84,685 | 0.5% | 3 |
| PMV PHARMACEUTICALS INC | [PMVP](https://holderbook.com/stocks/PMVP/) | $485.6K | 362,361 | 0.5% | 2 |
| NATIONAL HEALTHCARE CORP | [NHC](https://holderbook.com/stocks/NHC/) | $485.1K | 2,295 | 0.5% | 1 |
| CIRRUS LOGIC INC | [CRUS](https://holderbook.com/stocks/CRUS/) | $484.9K | 3,265 | 0.5% | 2 |
| MICRON TECHNOLOGY INC | [MU](https://holderbook.com/stocks/MU/) | $483.6K | 419 | 0.5% | 3 |
| JONES LANG LASALLE INC | [JLL](https://holderbook.com/stocks/JLL/) | $481.0K | 1,552 | 0.5% | 6 |
| APA CORPORATION | [APA](https://holderbook.com/stocks/APA/) | $474.3K | 14,562 | 0.5% | 1 |
| RMR GROUP INC | [RMR](https://holderbook.com/stocks/RMR/) | $461.8K | 22,496 | 0.4% | 1 |
| FULCRUM THERAPEUTICS INC | [FULC](https://holderbook.com/stocks/FULC/) | $458.3K | 125,224 | 0.4% | 1 |
| PROG HOLDINGS INC | [PRG](https://holderbook.com/stocks/PRG/) | $437.3K | 9,382 | 0.4% | 2 |
| SEPTERNA INC | [SEPN](https://holderbook.com/stocks/SEPN/) | $434.4K | 12,970 | 0.4% | 1 |
| BIOAGE LABS INC | [BIOA](https://holderbook.com/stocks/BIOA/) | $426.3K | 17,394 | 0.4% | 2 |
| TERADYNE INC | [TER](https://holderbook.com/stocks/TER/) | $424.8K | 878 | 0.4% | 3 |
| ARROW ELECTRS INC | [ARW](https://holderbook.com/stocks/ARW/) | $421.7K | 1,976 | 0.4% | 2 |
| INGLES MKTS INC | [IMKTA](https://holderbook.com/stocks/IMKTA/) | $419.3K | 4,734 | 0.4% | 1 |
| ERASCA INC | [ERAS](https://holderbook.com/stocks/ERAS/) | $411.5K | 22,460 | 0.4% | 2 |
| VIANT TECHNOLOGY INC | [DSP](https://holderbook.com/stocks/DSP/) | $403.6K | 31,880 | 0.4% | 1 |
| QUALCOMM INC | [QCOM](https://holderbook.com/stocks/QCOM/) | $399.3K | 2,161 | 0.4% | 1 |
| SHATTUCK LABS INC | [STTK](https://holderbook.com/stocks/STTK/) | $397.2K | 57,231 | 0.4% | 2 |
| ZURA BIO LTD | [ZURA](https://holderbook.com/stocks/ZURA/) | $394.8K | 66,919 | 0.4% | 2 |
| LAM RESEARCH CORP | [LRCX](https://holderbook.com/stocks/LRCX/) | $387.0K | 893 | 0.4% | 3 |
| SAVARA INC | [SVRA](https://holderbook.com/stocks/SVRA/) | $380.4K | 61,759 | 0.4% | 2 |
| MAZE THERAPEUTICS INC | [MAZE](https://holderbook.com/stocks/MAZE/) | $376.5K | 12,618 | 0.4% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +19.5% | +14.8% | +4.7% | 97% |
| Q1 2026 | +2.8% | -4.6% | +7.5% | 99% |
| Q4 2024 | -0.4% | +2.1% | -2.5% | 101% |
| Q3 2024 | +7.2% | +5.4% | +1.8% | 100% |
| Q2 2024 | -2.6% | +4.0% | -6.7% | 102% |
| Q1 2024 | +6.4% | +10.0% | -3.6% | 100% |
| Q4 2023 | +14.1% | +11.2% | +2.9% | 100% |
| Q3 2023 | -5.8% | -3.6% | -2.3% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $104.4M | 210 |
| Q1 2026 | $88.8M | 179 |
| Q4 2025 | $87.4M | 104 |
| Q3 2024 | $74.9M | 92 |
| Q2 2024 | $86.6M | 110 |
| Q1 2024 | $91.9M | 147 |
| Q4 2023 | $49.3M | 53 |
| Q3 2023 | $65.4M | 51 |
| Q2 2023 | $63.8M | 46 |
| Q1 2023 | $49.7M | 38 |
| Q4 2022 | $99.2M | 29 |
| Q3 2022 | $68.8M | 25 |